MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/s2055-6640(20)30504-5

Медицинская библиотека · Journal of virus eradication · 2015

HCV treatment in children and young adults with HIV/HCV co-infection in Europe.

Turkova Anna, Giacomet Vania, Goetghebuer Tessa, Miloenko Milana, Nicolini Laura Ambra, Noguera-Julian Antoni, Rojo Pablo, Volokha Alla, Indolfi Giuseppe, Giaquinto Carlo, Thorne Claire

СтатьяПеревод пока не подготовлен

Аннотация

OBJECTIVES

To describe use of treatment for chronic hepatitis C virus (HCV) infection in HIV/HCV co-infected children and young people living in Europe and to evaluate treatment outcomes.

METHODS

HCV treatment data on children and young people aged <25 years with HIV/HCV co-infection were collected in a cohort collaboration of 11 European paediatric HIV cohorts. Factors associated with receipt of HCV treatment and with sustained virological response 24 weeks after treatment completion (SVR24) were explored.

RESULTS

Of 229 HIV/HCV co-infected patients, 22% had a history of AIDS and of 55 who were treated for HCV, 47 (85%) were receiving combined antiretroviral therapy. The overall HCV treatment rate was 24% (n=55) but it varied substantially between countries, with the highest rate being in Russia at 61% (30/49). Other factors associated with treatment receipt were older age [adjusted odds ratio (AOR) 5.24, 95% confidence interval (CI) 1.9-14.4, for 18-24-year-olds vs 11-17-year-olds, P=0.001] and advanced fibrosis (AOR 5.5, 95% CI 1.3-23.7; for ≥9.6 vs ≤7.2 kPa, P=0.02). Of 50 patients with known treatment outcomes, 50% attained SVR24. Of these, 16 (80%) had genotype (GT) 2,3 and 8 (29%) had GT 1,4 (P<0.001). After adjusting for genotype (GT 1,4 vs GT 2,3), females (P=0.003), patients with non-vertical HCV acquisition (P=0.002) and those with shorter duration of HCV (P=0.009) were more likely to have successful treatment outcomes.

CONCLUSION

Only half of the HIV/HCV co-infected youth achieved an HCV cure. HCV treatment success appears to be lower in the context of HIV co-infection than in HCV mono-infection, underscoring the urgent need to speed up approvals of new direct-acting antiviral combinations in children.

Для цитирования: Turkova Anna, Giacomet Vania, Goetghebuer Tessa, Miloenko Milana, Nicolini Laura Ambra, Noguera-Julian Antoni, Rojo Pablo, Volokha Alla, Indolfi Giuseppe, Giaquinto Carlo, Thorne Claire. HCV treatment in children and young adults with HIV/HCV co-infection in Europe.. Journal of virus eradication. 2015. DOI: 10.1016/s2055-6640(20)30504-5.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.